Vincent Cottin Selected Research

Idiopathic Pulmonary Fibrosis

4/2022	Safety and tolerability of nintedanib in patients with progressive fibrosing interstitial lung diseases: data from the randomized controlled INBUILD trial.
1/2022	Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases.
1/2022	Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis.
1/2022	Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort.
1/2022	Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis.
1/2022	Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
1/2022	Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial.
9/2021	The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis.
3/2021	Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases.
1/2021	Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincent Cottin Research Topics

Disease

50	Idiopathic Pulmonary Fibrosis 04/2022 - 06/2007
28	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2022 - 04/2002
20	Pulmonary Arterial Hypertension 01/2022 - 07/2010
20	Pulmonary Hypertension 01/2022 - 04/2011
17	Tuberous Sclerosis (Bourneville's Disease) 09/2021 - 11/2014
15	Disease Progression 01/2021 - 11/2008
13	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2022 - 09/2012
12	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 10/2008
12	Fibrosis (Cirrhosis) 01/2020 - 04/2002
11	Lung Diseases (Lung Disease) 01/2022 - 06/2007
8	Neoplasms (Cancer) 01/2022 - 07/2006
8	Vasculitis (Vasculitides) 01/2022 - 06/2011
7	Sarcoidosis (Schaumann Disease) 01/2021 - 02/2010
7	Connective Tissue Diseases (Connective Tissue Disease) 01/2018 - 05/2010
7	Dyspnea (Shortness of Breath) 01/2018 - 05/2004
6	Emphysema 01/2022 - 06/2007
6	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 12/2007
6	Inflammation (Inflammations) 09/2021 - 07/2002
6	Asthma (Bronchial Asthma) 01/2021 - 01/2016
6	Hypoxia (Hypoxemia) 01/2021 - 06/2007
5	Respiratory Insufficiency (Respiratory Failure) 10/2022 - 01/2010
5	Churg-Strauss Syndrome (Allergic Angiitis) 01/2022 - 01/2016
5	Infections 01/2022 - 06/2015
5	Eosinophilia 01/2021 - 11/2012
5	Angiomyolipoma 01/2020 - 01/2010
5	Dermatomyositis (Dermatopolymyositis) 02/2019 - 12/2007
4	Diarrhea 04/2022 - 05/2014
4	Inborn Genetic Diseases (Disease, Hereditary) 09/2021 - 11/2014
4	Rare Diseases (Rare Disease) 01/2021 - 11/2014
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2020 - 01/2018
4	Exanthema (Rash) 01/2020 - 09/2014
4	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 01/2017
4	Pneumonia (Pneumonitis) 01/2019 - 03/2016
4	Pulmonary Alveolar Proteinosis 01/2019 - 01/2016
4	Myositis (Idiopathic Inflammatory Myopathies) 01/2019 - 05/2010
4	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2018 - 09/2014
3	Lung Injury 10/2022 - 07/2012
3	Weight Loss (Weight Reduction) 01/2022 - 01/2017
3	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2021 - 09/2015
3	Epilepsy (Aura) 01/2021 - 01/2019
3	Idiopathic Interstitial Pneumonias 01/2021 - 01/2017
3	Hypertension (High Blood Pressure) 01/2021 - 10/2019
3	Bronchiectasis 10/2020 - 06/2007
3	Cough 01/2020 - 01/2017
3	Pneumothorax 01/2019 - 11/2017
3	Antisynthetase syndrome 01/2019 - 05/2010
3	Opportunistic Infections (Opportunistic Infection) 01/2019 - 11/2014
3	Lung Neoplasms (Lung Cancer) 10/2018 - 07/2006
3	Hemorrhage 07/2017 - 05/2007
3	Arthralgia (Joint Pain) 01/2017 - 09/2014
3	Arteriovenous Malformations (Arteriovenous Malformation) 08/2016 - 05/2004
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2015 - 05/2013
3	Respiratory Sounds (Crackle) 04/2014 - 12/2007
3	Rheumatoid Arthritis 01/2011 - 04/2005
2	Body Weight (Weight, Body) 01/2022 - 01/2016
2	Seizures (Absence Seizure) 01/2021 - 03/2019
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 09/2014
2	Infantile Spasms (West Syndrome) 01/2021 - 03/2019
2	Mononeuropathies (Mononeuritis Multiplex) 10/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

22	nintedanibIBA 04/2022 - 05/2014
18	trans-sodium crocetinate (crocetin)IBA 09/2021 - 11/2014
17	pirfenidoneIBA 01/2022 - 01/2013
14	Carbon MonoxideIBA 01/2022 - 06/2007
14	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 10/2002
10	lipoarabinomannan (LAM)IBA 09/2021 - 09/2012
9	AutoantibodiesIBA 01/2019 - 05/2007
7	Pharmaceutical PreparationsIBA 10/2022 - 11/2012
7	Biomarkers (Surrogate Marker)IBA 09/2021 - 11/2014
7	Biological ProductsIBA 10/2020 - 03/2013
6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 10/2008
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 12/2007
5	AntibodiesIBA 01/2019 - 12/2007
4	GlucocorticoidsIBA 01/2022 - 12/2019
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 04/2015
4	TOR Serine-Threonine KinasesIBA 01/2021 - 09/2015
4	Oxygen (Dioxygen)IBA 01/2021 - 05/2004
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
4	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 02/2019 - 05/2010
3	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2016
3	SteroidsIBA 01/2021 - 02/2010
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2021 - 09/2015
3	Surface-Active Agents (Surfactants)IBA 12/2020 - 01/2018
3	Immunosuppressive Agents (Immunosuppressants)IBA 12/2019 - 06/2011
3	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2018 - 04/2014
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 06/2015 - 01/2011
2	treprostinil FDA Link 01/2022 - 05/2021
2	TabletsIBA 01/2022 - 06/2020
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 01/2020
2	Everolimus FDA Link 01/2021 - 09/2015
2	riociguatIBA 01/2021 - 01/2019
2	Rituximab (Mabthera)FDA Link 10/2020 - 01/2018

Therapy/Procedure

49	Therapeutics 01/2022 - 05/2004
7	Lung Transplantation 01/2022 - 01/2010
4	Drug Therapy (Chemotherapy) 01/2020 - 07/2006
4	Transplantation 01/2020 - 03/2013
3	Plasma Exchange 01/2020 - 06/2011
3	Pleurodesis 01/2019 - 01/2010
3	Radiotherapy 03/2016 - 12/2005
2	Immunomodulation 03/2021 - 12/2018
2	Liver Transplantation 01/2020 - 04/2002